Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRE-ERODE: Qing Re Huo Xue in Rheumatoid Arthritis
NCT04170504Phase 3Completed
- Sponsor
- Guang'anmen Hospital
- Start
- Nov 2019
- Primary completion
- Jun 2022
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of qing re huo xue in rheumatoid arthritis (RA), sponsored by Guang'anmen Hospital. Started Nov 2019; status: completed.
02
Drugs
qing re huo xue
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT04170504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04170504.